The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure
- 14 February 2000
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 235 (1-2) , 81-90
- https://doi.org/10.1016/s0022-1759(99)00223-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America.Proceedings of the National Academy of Sciences, 1996
- Monoclonal Antibodies in Rabies TherapyClinical Immunotherapeutics, 1994
- Production of Human Monoclonal Antibodies Against Rabies VirusPublished by Springer Nature ,1994
- Development of Human Monoclonal Antibodies to RabiesHybridoma, 1994
- Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.Proceedings of the National Academy of Sciences, 1992
- Affinity chromatographic purification of immunoglobulin M antibodies utilizing immobilized mannan binding proteinJournal of Chromatography A, 1992
- A Rabies-Specific Human Monoclonal Antibody That Protects Mice Against Lethal RabiesHybridoma, 1991
- Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.Journal of Clinical Investigation, 1989
- Antigenic Sites on the CVS Rabies Virus Glycoprotein: Analysis with Monoclonal AntibodiesJournal of General Virology, 1983
- Chemical and immunological analysis of the rabies soluble glycoproteinVirology, 1983